A COVID-19 expert shares his simple sports analogy to explain why vaccines work against variants
- There's concern coronavirus
variantscan partially evade vaccines made to target the original virus.
- But research suggests the parts of our immune system activated by vaccines can still fight variants.
- Experts say to think of vaccines like an elite athlete: They can dominate even when off their A game.
For a while, Dr. Jeremy Faust struggled to put into words why he was not worried about
Faust, an emergency-medicine physician and instructor at Harvard Medical School, was loath to use data to explain his reasoning to nonscientists. Instead, he had a hunch that sports analogies might help people understand him a little better.Recently, he came up with one comparison that seemed to resonate: Think of our COVID-19 vaccines as world-class athletes.
Pfizer's, Moderna's, and Johnson & Johnson's COVID-19 shots, which were all 100% effective at preventing hospitalizations and deaths in clinical trials of tens of thousands of people around the world, are kind of like the Williams or the Brady of vaccines.Yes, viral variants are on the rise - some of which can evade virus-neutralizing antibodies. But make no mistake: These vaccines, like elite athletes, can still perform very well against them.
"If Serena Williams all of a sudden was 10% less effective than usual, or 50% less effective than usual, she would still kick everyone's ass," Faust, who is also the editor of Brief19, a daily review of COVID-19 research, recently told Insider on Clubhouse."So far, the variants have not rendered any of the vaccines useless," Faust said, adding that like Williams or Brady, "they're still quite impressive," even when slightly less effective.
Fauci agrees: Vaccines are tough to beat, even for variantsCOVID-19 vaccines help our bodies prepare for the possibility of a future
Concerns that these shots could then be less effective against variants come from lab studies involving blood samples from vaccinated people, which showed that vaccinated people produced far fewer antibodies that could neutralize variants compared with the antibodies produced to combat the wild-type virus.
But Dr. Anthony Fauci, who spoke with Insider last week, stressed that drop wasn't enough to render vaccines ineffective.These authorized vaccines are also 66 to 95% effective at preventing sickness - far surpassing the US Food and Drug Administration's 50% efficacy bar for COVID-19 vaccines, making consumers "spoiled," some vaccine makers have suggested.
"Most people have high enough levels of antibody that even if you diminish it by several fold, we still have enough cushion effect to be able to block any issue of severe disease," Fauci told Insider.
Like elite athletes, it would take a lot to overcome our highly effective COVID-19 vaccines
Scientists still don't know precisely the amount of antibodies needed to keep us safe from a severe COVID-19 infection (just like we don't know at what point a fatigued Brady or an injured Williams would cease to be some of the greatest athletes of all time).But, like elite athletes, existing COVID-19 vaccines prompt such a high level of response to start with that even a little kick in the knees from some variants won't completely stymie their efficacy, according to Alessandro Sette, an infectious-disease expert at the La Jolla Institute for Immunology in California.
"It's like you have a bug spray that is supposed to kill mosquitoes but might kill flies too, though maybe not as well," Sette said.
Besides, that stark drop observed in neutralizing antibodies doesn't happen against every variant. The variant first found in the UK, which is the one that is dominant in the US now, is "handled extremely well by the vaccines that are currently in use," Fauci said.
Our T cells respond equally well to variants as they do to the original virusConcerns over plummeting antibody levels also don't take into account other parts of our immune response to the virus - namely killer T cells that identify and kill infected cells, as well as helper T cells that help B cells make new antibodies. While antibodies stop infection, your body's T cell response - which lasts at least six to eight months - can influence how severe that infection will be.
Sette compares this phenomenon to people's facial-recognition skills."Maybe I learn to recognize your face, then I meet your sister," he said. "It kind of looks like you, so I say, 'OK, that's probably someone related.'"
One study - led by researchers at the National Institute of Allergy and Infectious Diseases, which Fauci directs - looked at blood samples from 30 people who'd gotten infected with the coronavirus before the emergence of the variants. It found that the patients' T cells did indeed respond to the variants first identified in South Africa, Brazil, and the UK well enough to give protection.
Sette's team reached the same conclusion. Its recent research found that after people recovered from the original virus, their T cells could respond to those three variants, as well as one first identified in Southern California.The La Jolla researchers also looked at blood samples from people who'd gotten Pfizer's or Moderna's shots and found that their T cells responded just as well to the variants first found in the UK, Brazil, and Southern California as they did to the original virus.
The likeliest explanation for why the same set of T cells can recognize different variants, according to Fauci, is a phenomenon called cross-reactivity: Helper and killer T cells developed in response to a given virus are capable of reacting to a similar but previously unknown variant.
Top athletes can perform well even when the game changes. These COVID-19 vaccines are the same.Great athletes can still perform relatively well when the game changes.
LeBron James was training for the NFL during the NBA's 2011 lockout. Michael Jordan played baseball after initially retiring from the NBA in 1993 (albeit, not nearly as well), and he's got a decent golf game, too.The only problem when it comes to the performance of our vaccines is: We just don't quite know where their limits might lie. "I worry more about the next variant than the current ones," Faust said.
There may someday be some variant that will pack a wallop to our authorized vaccines, which would make booster shots essential.
But until then, the human body, when primed by a
- India records highest single-day rise of 2,61,500 COVID-19 cases and 1,501 deaths
- Odisha halts COVID-19 vaccination drive in 1,035 sites due to its acute shortage
- All Migrant workers coming to Uttar Pradesh to be quarantined
- Microsoft Remote Desktop for macOS updated with M1 chip support
- GoaMiles, a new state-backed cab aggregator service in tourists' hub has the taxi drivers on strike for 10 days